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Abstract: Sulphydryl-containing captopril
(CPR) appears to act as a scavanger of
oxygen derived free radicals. This is not
present in other angiotensin-converting
enzymes such as enalapril (EPR). The
hepatotoxic effect of carbon tetrachloride
(CCl4) may result from induction of reactive
oxygen free radicals. The aim of this study
was to analyse the effects of CPR and nonsulphydryl-containing enalapril (EPR) in
healthy rats and in rats with CCL4-induced
toxic hepatitis.
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The rats were divided into two major groups.
The first group consisted of healthy rats, and
the second group consisted of rats with CCl4induced toxic hepatitis. Each major group
was sub-divided into 3 groups, where CPR,

Introduction
The effects of most angiotensin-converting enzyme
inhibitors (ACEI), and captopril (CPR) in particular,
cannot be explained solely on the basis of their enzymeinhibiting activity. Sulphydryl (-SH)-containing captopril
appears to act as a scavanger of oxygen-derived free
radical species, suggesting its potential importance in
reversing post-ischaemic contractile dysfunction and
myocyte necrosis. However, the free radical scavenging
effects of ACEIs , is probably not related solely to their
sulphydryl content (1,2). Enalapril (EPR), and other
ACEIs do not contain a sulphydryl group.
Various pharmacological and chemical substances are
known to lead to liver damage. One of these chemicals is
carbon tetrachloride (CCl4). CCl4 and its metabolites
induce peroxidation of cell membrane lipids, regeneration
of reactive oxygen free radicals, and hepatocellular fatty
regeneration with centrolobular necrosis of the liver (3).
The aim of this study was to analyse the biochemical
and histopathological effects of captopril (CPR) and

EPR, or a placebo was administered. The
resulting 6 sub-groups were analysed for the
hepatic effects of CPR and EPR in healthy
rats and in rats with CCl4-induced toxic
hepatitis.
Co-administration of CPR or EPR with CCl4
lead to an increase in hepatic enzyme levels,
and to a greater level of liver damage in
comparison with CCl4 alone.
In conclusion, both CPR and EPR may lead to
hepatotoxicity, and sulphydryl-containing
CPR does not appear to protect the liver
from the toxic oxidant effect of CCl4.
Key Words: Captopril, enalapril, carbon
tetrachloride, hepatotoxicity.

enalapril (EPR) in healthy rats and in rats with CCL4induced toxic hepatitis, and to investigate whether
sulphydryl-containing CPR protects the liver from the
toxic oxidant effect of CCl4.
Materials and Methods
Sixty male rats, each weighing an average of 150g,
were used for the purpose of this study. The rats were
divided into two major groups. The first group consisted
of healthy rats, and the second group consisted of rats
with CCl4-induced toxic hepatitis. Each major group was
sub-divided into 3 groups (A;B;C and D;E;F), each of
which contained 10 rats. The study groups in this
experiment are summarised in Table 1. CCl4 was
administered to the rats on the first day of the
experiment. CPR was administered at 5mg/kg three
times and EPR at 1mg/kg twice for the first three days of
the study. The doses of CPR and EPR were chosen
according to the recommendations of Przyklenk & Kloner
(1). Sterile saline (SS) was used as the control.
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Table 1.

Healthy Rats

Rats with CC14induced toxic
hepatitis

SubGroups

Intraperitoneal
Injection

Intragastric
Administration

A

1 mL SS

1 mL SS twice
daily for 3 days

B

1 mL SS

15 mg/kg CPR
thrice daily for 3 days

C

1 mL SS

2 mg/kg EPR
twice daily for 3 days

D

0.5 mL/kg CCl4

1 mL SS twice
daily for 3 days

E

0.5 mL/kg CCl4

15 mg/kg CPR

F

0.5 mL/kg CCl4

thrice daily for 3 days
2 mg/kg EPR
twice daily for 3 days

Study groups in the experiment

CCl4: Carbontetrachloride
SS:
Sterile Saline
CPR: Captopril
EPR: Enalapril

The CCl4 used in the study was a solution purchased
from Sigma Laboratories (Cat no: C5331). The CPR and
EPR were diluted in 1 ml of SS for groups B, C, E and F
prior to administration. Intracardiac blood samples were
collected from the rats, and their livers were removed on
the fourth day of the experiment immediately after they
were sacrificed by air embolus injection. Alkaline
phosphatase (ALP), aspartate aminotransferase (AST),
alanine aminotransferase (ALT), total bilirubin, and
conjugated bilirubin were determined with a Technicon
RA-XT autoanalyser kits. The liver preparations were
evaluated by a pathologist, who had not been informed of
the particular groups of the specimens. Hepatic damage
was graded according to the presence of histopathological
characteristics on a scale of 1 to 7, as detailed in Table 2
(4). A hepatic damage score was obtained for each rat
according to the presence of one or more of these
characteristics, and the mean hepatic damage score for
the 10 rats in each of the groups A, B, C, D, E and F was
estimated (Table 3).
Biochemical parameters and hepatic scores were
analysed by employing Kruskal Wallis and Mann-Whitney
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U tests, and values of p<0.05 were accepted as being
statistically significant.
Results
The means of the biochemical parameters, and
statistical comparisons of the groups are presented in
Table 3.
ALP levels were found to be significantly increased
(p<0.05) in comparison with the control group when
ACEIs alone were administered. ALP levels were increased
in all CCl4 containing groups in comparison with the
control and ACEI-only groups. The highest increase in
ALP levels was in the CCl4-with-CPR group.
The AST values for the ACEI-only groups and the
control group were similar. AST values were significantly
increased in the CCl4 group in comparison with the
control and ACEI-only groups. Addition of CPR or EPR to
the CCl4 led to even higher levels of AST, though this was
only significant between the CCl4-with-EPR versus the
CCl4-only groups.
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Table 2.
Hepatic damage score

Histological finding

1

congestion of less than half of the liver lobule

2

congestion of more than half of the liver lobule

3

microvesiculation

4

focal necrosis around the central vein

5

necrosis of 1/3 of the distance between the
central vein and portal tract

6

necrosis of 2/3 of the distance between the central
vein and portal tract

7

necrosis of all of the distance between the central
vein and portal tract

There was a slight increase in the levels of ALT in the
ACEI-only groups in comparison with the control group,
though this was only significant in the CPR-only group.
There was a statistically significant increase in ALT in all
CCl4-containing goups in comparison with the control
and ACEI-only groups. The administration of CPR or EPR
together with CCl4 led to a greater increase in ALT levels
than with CCl4 alone.
There was no statistical difference between the
control and ACEI-only groups with respect to the total
bilirubin levels. The CCl4-containing groups led to a
statistically significant increase in the total bilirubin level,
but the effect of co-administration of ACEI with CCl4 was
similar to that of CCl4 alone. The findings for conjugated
bilirubin were similar to those for total bilirubin, with the
exception that administration of ACEI with CCl4 led to a
significantly higher increase in comparison with CCl4
alone.
Histological examination of the liver tissues in the
control and ACEI-only groups revealed only minimal
congestion. However, there was significant liver damage
in all CCl4-containing groups, most of which exhibited
congestion, microvesiculation and necrosis. Concurrent
administration of CPR or EPR with CCl4 led to
significantly greater liver damage in comparison with
CCl4 alone, showing extension of the necrosis. The
hepatic damage scores were in agreement with these
findings, showing higher scores for groups E and F
(Table 3).

Hepatic damage scoring system.

Discussion
Various pharmacological and chemical substances
which belong to the intrinsic or idiosyncratic group of
hepatotoxins may induce a level of hepatic damage
varying from asymptomatic hepatic functional
disturbance to widespread liver necrosis. CCl4, which is
an intrinsic hepatotoxin, was used for the purpose of
inducing hepatic damage in this study (5). The sulphydryl
content of the CPR did not translate into an advantage
over EPR in terms of preventing CCl4-induced hepatic
damage, which was similar in both groups.
The hepatotoxicity of CCl4 was confirmed in this
study with significant elevations of ALP, AST, ALT, total
bilirubin, conjugated bilirubin and hepatic damage scores.
CPR or EPR alone also led to an elevation in ALP levels.
CCl4 hepatotoxicity was more marked when it was used
concurrently with ACEIs. There are two possible
mechanisms for this. Firstly, it is known that ACEIs can
result in greater hypotension in the presence of
hepatoxicity (6). Therefore, it is possible that hypotension
secondary to ACEI administration decreases liver
perfusion, causing secondary hypoxia and exacerbating
the hepatotoxicity caused by CCl4. The healthy rats may
have tolerated a degree of reduction in liver perfusion,
but it is unlikely that the rats with impaired liver function
could have tolerated this. Secondly, ACEIs may have a
direct cytotoxic effect on the liver (7,8), and this may
have exacerbated the CCl4 toxicity. The blood pressure of
the rats could not be studied in this experiment due to
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Table 3.

ParaMeter

Biochemical and Histopathological findings.

A

B

C

D

E

F

ALP
(U/L)

65
±
11

105
±
10

102
±
37

171.5
±
33

342
±
148

179
±
47

A<B*, A<C*, A<D*, A<E**, A<F*, B<D*,
B<E**, C<D*, C<F*, D<E*, E<F*

AST
(U/L)

178
±
70

155
±
13

176
±
70

8686
±
6536

10700
±
7662

12246
±
7864

A<D , A<E , A<F , B<D , B<E , C<D ,
D<F

ALT
(U/L)

28±11

42
±
12

36
±
16

1873
±
1107

3375
±
2738

3144
±
1408

A<B*, A<D , A<E , A<F , B<D , B<E ,
C<D , C<F

Total

2.42

2.30

2.52

10.0

12.3

13.7

A<D*, A<E*, A<F*, B<D*, B<E*,

bilirubin
(µmol/K)

±
1.17

±
1.7

±
1.7

±
8.5

±
5.1

±
8.5

C<D*, C<F*

C. bilirubin
(µmol/L)

0.51
±
.0.17

0.34
±
0.13

0.40
±
0.17

6.80
±
0.51

8.8
±
5.1

9.3
±
6.8

A<D , A<E , A<F , B<D , B<E, C<D,
C<D , C<F , D<E*, D<F*

1.2
±
0.4

1.1
±
0.3

1.3
±
0.4

7.5
±
2.8

9.5
±
3.1

8.9
±
2.1

A<D , A<E , A<F , B<D , B<E , C<D,
C<F , D<E*, D<F*

Hepatic
Damage

Statistical Significance

*p<0.05, **p<0.01, p<0.001,
Values are presented as mean ± standard deviation.
Only relationships of statistical significance are presented in the table.
T bilirubin: Total bilirubin, C bilirubin: Conjugated bilirubin, ALP: Alkaline phosphatase, AST: Aspartate Aminotransferase,
ALT : Alanine aminotransferase
A: Intraperitoneal + oral sterile saline (SS),
B: Intraperitoneal SS + oral 15 mg/kg/day CPR
C: Intraperitoneal SS + oral 2 mg/kg/day EPR
D: Intraperitoneal 0.5 ml/kg CC14 + oral sterile saline
E: Intraperitoneal 0.5 ml/kg CC14 + oral 15 mg/kg/day CPR
F: Intraperitoneal 0.5 ml/kg CC14 + oral 2 mg/kg/day EPR

technical difficulties. In addition to the mechanisms of
toxicity described above, CPR can, rarely, cause
cholestatic liver damage in humans, which is reversed in
most patients upon withdrawal of the drug (9,10).
However, jaundice may continue for several weeks in a
number of patients, and finally lead to widespread liver
necrosis, hepatic coma, and death (11). EPR is also
known to lead to hepatoxicity, albeit less frequently than
CPR (12).
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In conclusion, both CPR and EPR may lead to
hepatotoxicity, and sulphydryl-containing CPR does not
appear to protect the liver from the toxic oxidant effect
of CCl4.
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